Page last updated: 2024-09-05

erlotinib hydrochloride and Coin Lesion, Pulmonary

erlotinib hydrochloride has been researched along with Coin Lesion, Pulmonary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cruz, P; de Castro, J; de Lujan, L	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Coin Lesion, Pulmonary

Article	Year
Management Difficulties in a Patient with EGFR-mutation Positive Lung Adenocarcinoma and Cerebral Metastases. Archivos de bronconeumologia, 2017, Volume: 53, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Genes, erbB-1; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Remission Induction; Salvage Therapy; Solitary Pulmonary Nodule; Tomography, X-Ray Computed	2017

Article

Year

Management Difficulties in a Patient with EGFR-mutation Positive Lung Adenocarcinoma and Cerebral Metastases.

Archivos de bronconeumologia, 2017, Volume: 53, Issue:1

Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Genes, erbB-1; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Remission Induction; Salvage Therapy; Solitary Pulmonary Nodule; Tomography, X-Ray Computed

2017